<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04236154</url>
  </required_header>
  <id_info>
    <org_study_id>19-007775</org_study_id>
    <nct_id>NCT04236154</nct_id>
  </id_info>
  <brief_title>&quot;Prescribing&quot; Exercise to Cancer Patients at High-Risk for Falls</brief_title>
  <official_title>&quot;Prescribing&quot; Exercise to Cancer Patients at High-Risk for Falls</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Andersen Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Falls are common and catastrophic in cancer patients. Cancer patients are vulnerable to falls
      due to muscle loss. In prescribing exercise in a data driven manner to cancer patients our
      hypothesis is this &quot;prescription&quot; for exercise will reduce the occurrence of injurious falls.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ABC Activities Specific Balance Confidence Scale (exploratory outcome)</measure>
    <time_frame>Change from baseline ABC scale at 4-6 weeks</time_frame>
    <description>Patient Reported Outcome 0% No confidence, 100% Complete Confidence, higher score= better outcome</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Cancer, Cancer Nonmelanoma Skin</condition>
  <arm_group>
    <arm_group_label>10%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Increase exercise daily step count by 10% above individual baseline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Increase exercise daily step count by 20% above individual baseline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Increase exercise daily step count by 30% above individual baseline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>50%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Increase exercise daily step count by 50% above individual baseline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>80%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Increase exercise daily step count by 80% above individual baseline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pedometer</intervention_name>
    <description>Participants will wear a pedometer for 4 days at baseline, and 4-6 weeks later. Baseline readings will be used to derive an individualized exercise program for each participant based on their assigned experimental arm.</description>
    <arm_group_label>10%</arm_group_label>
    <arm_group_label>20%</arm_group_label>
    <arm_group_label>30%</arm_group_label>
    <arm_group_label>50%</arm_group_label>
    <arm_group_label>80%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Actigraph</intervention_name>
    <description>Participants will wear a Actigraph for 4 days at baseline and 4-6 weeks later. Baseline readings will be used to derive an individualized exercise program for each participant based on their assigned experimental arm.</description>
    <arm_group_label>10%</arm_group_label>
    <arm_group_label>20%</arm_group_label>
    <arm_group_label>30%</arm_group_label>
    <arm_group_label>50%</arm_group_label>
    <arm_group_label>80%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Perturbation Treadmill</intervention_name>
    <description>Participants will walk on an instrumented treadmill while wearing a safety harness at baseline and 4-6 weeks later. The perturbation treadmill will assess an individual's risk for falling. Baseline readings will be used to derive an individualized exercise program for each participant based on their assigned experimental arm.</description>
    <arm_group_label>10%</arm_group_label>
    <arm_group_label>20%</arm_group_label>
    <arm_group_label>30%</arm_group_label>
    <arm_group_label>50%</arm_group_label>
    <arm_group_label>80%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any cancer diagnosis, as documented in medical record, other than non-melanoma skin
             cancer.

          -  No issues such as unstable angina or loss of a limb that would preclude exercise.

        Exclusion Criteria:

          -  Diagnosis of non-melanoma skin cancer

          -  Unstable angina

          -  Loss of limb, which limits exercise capabilities at the discretion of the Principal
             Investigators

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christine Huyber</last_name>
    <phone>507-266-0984</phone>
    <email>huyber.christine@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kathie Bernhardt</last_name>
    <phone>507-266-0985</phone>
    <email>bernhardt.kathie@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Huyber, BS</last_name>
      <phone>507-266-0984</phone>
      <email>huyber.christine@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kathie Bernhardt</last_name>
      <phone>507-266-0985</phone>
      <email>bernhardt.kathie@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Aminah Jatoi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 16, 2020</study_first_submitted>
  <study_first_submitted_qc>January 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2020</study_first_posted>
  <last_update_submitted>July 10, 2020</last_update_submitted>
  <last_update_submitted_qc>July 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Aminah Jatoi, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Exercise, Falls</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

